株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の疼痛管理療法市場 (治療法別 (抗けいれん薬、抗うつ薬、麻酔薬、NSAID、オピオイド)・適応症別):産業分析・規模・シェア・成長率・動向・予測

Pain Management Therapeutics Market (Therapeutics - Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs, Opioids; Indication) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2023

発行 Transparency Market Research 商品コード 277689
出版日 ページ情報 英文 130 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
世界の疼痛管理療法市場 (治療法別 (抗けいれん薬、抗うつ薬、麻酔薬、NSAID、オピオイド)・適応症別):産業分析・規模・シェア・成長率・動向・予測 Pain Management Therapeutics Market (Therapeutics - Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs, Opioids; Indication) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2023
出版日: 2016年08月01日 ページ情報: 英文 130 Pages
概要

当レポートでは、世界の疼痛管理療法市場について調査し、主な市場促進・抑制要因や今後の市場機会、治療法別 (抗けいれん薬、抗うつ薬、麻酔薬、NSAIDs、オピオイドなど) および適応症別の市場動向見通し、各地域市場・主要国市場の詳細動向、主要企業のプロファイル・市場シェアといった情報を取りまとめてお届けいたします。

第1章 序論

第2章 エグゼクティブ・サマリー

第3章 世界の疼痛管理療法市場:産業分析

  • 市場のダイナミクス
    • 市場成長促進因子
    • 市場成長阻害因子
    • 市場機会
  • 市場求心力の分析
  • 治療薬別の市場収益額 (今後11年間分)
    • 概要
    • 抗けいれん薬
    • 抗うつ薬
    • 麻酔薬
    • NSAIDs (非ステロイド性抗炎症薬)
    • オピオイド
    • 抗片頭痛薬
    • その他の非麻薬性鎮痛薬
  • 適応症別の市場収益額 (今後11年間分)
    • 概要
    • 神経因性疼痛
    • 線維筋痛
    • 関節痛
    • 慢性腰痛
    • 偏頭痛
    • 術後疼痛
  • がん性疼痛
  • 市場シェア分析

第4章 北米市場の動向見通し (金額ベース、今後11年間分)

  • 主要動向の分析
  • 治療薬別
  • 適応症別

第5章 欧州市場の動向見通し (金額ベース、今後11年間分)

第6章 アジア太平洋地域市場の動向見通し (金額ベース、今後11年間分)

第7章 他の国々 (RoW) の市場の動向見通し (金額ベース、今後11年間分)

第8章 主要国市場の概況 (金額ベース、今後11年間分)

  • 概要
  • 米国
  • カナダ
  • 英国
  • ドイツ
  • 中国
  • 日本
  • ブラジル
  • メキシコ

第9章 企業プロファイル

  • Abbott Laboratories
  • AstraZeneca
  • Depomed, Inc.
  • Endo Pharmaceuticals, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Mallinckrodt Pharmaceuticals
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer, Inc.
  • Purdue Pharma L.P.
  • Teva Pharmaceutical Industries Limited

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Title: Pain Management Therapeutics Market (Therapeutics - Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids (Oxycodones, Hydrocodones, Tramadol), Antimigraine Agents, Other Non-narcotic Analgesic; Indication - Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine, Post-operative Pain, Cancer Pain) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2023.

This report on the pain management therapeutics market studies the current as well as future prospects of the market globally. The pain management therapeutics market report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the general information and data analysis of the global pain management therapeutics market with respect to the leading market segments based on major therapeutics, and geographies.

The global pain management therapeutics market has been studied based on major segments by therapeutics, by indication and their regional as well as national markets. Based on therapeutics, the global market has been segmented into anticonvulsants, antidepressants, anesthetics, non-steroidal anti-inflammatory drugs (NSAIDS), opioids, other non-narcotic analgesic, and antimigraine agents. Further the market has been segmented according to its indication that includes neuropathic pain, fibromyalgia, arthritic pain, chronic back pain, migraine, post-operative pain, and cancer pain. The market for these segments has been extensively analyzed based on their effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2015 as the base year.

The market overview section of the report explores the dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the pain management therapeutics market and could influence the market in the near future. Market attractiveness analysis has been provided in the overview section in order to explain the intensity of competition across different geographies. The competitive scenario among different players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players to take strategic decisions in order to strengthen their position and expand their shares in the global pain management therapeutics market.

Geographically, the pain management therapeutics market has been segmented into four regions: North America, Europe, Asia Pacific, and Rest of the World(RoW). Each regional pain management therapeutics market has been further categorized into major national markets such as the U.S, Canada, Germany, the U.K., Japan, China, Brazil, and Mexico. Market revenue in terms of US$ Mn for the period from 2014 to 2024 along with CAGR % from 2016 to 2024 are provided for all the regions and nations considering 2015 as the base year.

The recommendations section included in the report would assist existing market players to expand their market shares, and new companies in establishing their presence in the global pain management therapeutics market. The report also profiles key players operating in this market based on various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include Abbott Laboratories, AstraZeneca, Depomed, Inc., Endo Pharmaceuticals, Inc., GlaxoSmithKline plc, Johnson & Johnson, Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Novartis AG, Pfizer, Inc., Purdue Pharma L.P., and Teva Pharmaceutical Industries Limited.

The global pain management therapeutics market is segmented as follows:

Global Pain Management Therapeutics Market Revenue, by Therapeutics

  • Anticonvulsants
  • Antidepressants
  • Anesthetics
  • Non-steroidal Anti-inflammatory Drugs (NSAIDS)
  • Opioids
    • Oxycodones
    • Hydrocodones
    • Tramadol
    • Others (Morphine, Codeine, Fentanyl, Meperidine, Methadone)
  • Antimigraine Agents
  • Other Non-narcotic Analgesic

Global Pain Management Therapeutics Market Revenue, by Indication

  • Neuropathic Pain
  • Fibromyalgia
  • Chronic Back Pain
  • Arthritic Pain
  • Migraine
  • Post-operative Pain
  • Cancer Pain

Global Pain Management Therapeutics Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Asia Pacific (APAC)
    • China
    • Japan
  • Rest of the World (RoW)
    • Brazil
    • Mexico

Table of Contents

1. Preface

  • 1.1. Report Description
  • 1.2. Market Segmentation
  • 1.3. Research Methodology

2. Executive Summary

  • 2.1. Pain Management Therapeutics Market, 2016-2024: Market Snapshot
  • 2.2. Global Pain Management Therapeutics Market Share, by Geography,2015,2024
  • 2.3. Global Pain Management Therapeutics Market Revenue, By Therapeutics, (US$ Mn), 2015
  • 2.4. Global Pain Management Therapeutics Market Revenue, By Indication, (US$ Mn), 2015

3. Global Pain Management Therapeutics Market - Industry Analysis

  • 3.1. Market Dynamics
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase in incidence of chronic pain disorders
      • 3.1.1.2. Rise in geriatric population with high risk of various diseases
      • 3.1.1.3. Growing adoption of pain management therapeutics among end-users
      • 3.1.1.4. Favorable regulatory scenario and health care reforms
    • 3.1.2. Restraints
      • 3.1.2.1. Patent expiry of key drugs and entry of generics
      • 3.1.2.2. Prescription drug abuse
      • 3.1.2.3. Long term pain relief from surgical procedures, alternative therapies, and medical devices
    • 3.1.3. Opportunities
      • 3.1.3.1. Asia Pacific holds immense potential for pain management therapeutics
      • 3.1.3.2. Launch of novel molecule combinations and drug delivery techniques
  • 3.2. Market Attractiveness Analysis
  • 3.3. Global Pain Management Therapeutics Market Revenue, By Therapeutics, (US$ Mn), 2014-2024
    • 3.3.1. Overview
    • 3.3.2. Anticonvulsants
    • 3.3.3. Antidepressants
    • 3.3.4. Anesthetics
    • 3.3.5. Non-steroidal Anti-inflammatory Drugs (NSAIDS)
    • 3.3.6. Opioids
      • 3.3.6.1. Overview
      • 3.3.6.2. Oxycodones
      • 3.3.6.3. Hydrocodones
      • 3.3.6.4. Tramadol
      • 3.3.6.5. Others (Morphine, Codeine, Fentanyl, Meperidine, Methadone)
    • 3.3.7. Antimigraine Agents
    • 3.3.8. Other Non-narcotic Analgesic
  • 3.4. Global Pain Management Therapeutics Market Revenue, by Indication, (US$ Mn), 2014-2024
    • 3.4.1. Overview
    • 3.4.2. Neuropathic Pain
    • 3.4.3. Fibromyalgia
    • 3.4.4. Arthritic Pain
    • 3.4.5. Chronic Back Pain
    • 3.4.6. Migraine
    • 3.4.7. Post-operative Pain
    • 3.4.8. Cancer Pain
  • 3.5. Market Share Analysis

4. North America Pain Management Therapeutics Market Revenue, (US$ Mn), 2014-2024

  • 4.1. Key Trend Analysis
  • 4.2. North America Pain Management Therapeutics Market by Therapeutic
  • 4.3. North America Pain Management Therapeutics Market by Indication

5. Europe Pain Management Therapeutics Market Revenue, (US$ Mn), 2014-2024

  • 5.1. Key Trend Analysis
  • 5.2. Europe Pain Management Therapeutics Market by Therapeutic
  • 5.3. Europe Pain Management Therapeutics Market by Indication

6. Asia Pacific Pain Management Therapeutics Market Revenue, (US$ Mn), 2014-2024

  • 6.1. Key Trend Analysis
  • 6.2. Asia Pacific Pain Management Therapeutics Market by Therapeutic
  • 6.3. Asia Pacific Pain Management Therapeutics Market by Indication

7. Rest of World Pain Management Therapeutics Market Revenue, (US$ Mn), 2014-2024

  • 7.1. Key Trend Analysis
  • 7.2. Rest of World Pain Management Therapeutics Market by Therapeutic
  • 7.3. Rest of World Pain Management Therapeutics Market by Indication

8. Country Snippet

  • 8.1. Overview
  • 8.2. U.S. Pain Management Therapeutics Market Revenue, (US$ Mn) 2014-2024
  • 8.3. Canada Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • 8.4. U.K. Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • 8.5. Germany Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • 8.6. China Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • 8.7. Japan Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • 8.8. Brazil Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • 8.9. Mexico Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024

9. Company Profiles

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Product Portfolio
    • 9.1.3. Financial Overview
    • 9.1.4. Business Strategy
    • 9.1.5. Recent Developments
  • 9.2. AstraZeneca
    • 9.2.1. Company Overview
    • 9.2.2. Product Portfolio
    • 9.2.3. Financial Overview
    • 9.2.4. Business Strategy
    • 9.2.5. Recent Developments
  • 9.3. Depomed, Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Product Portfolio
    • 9.3.3. Financial Overview
    • 9.3.4. Business Strategy
    • 9.3.5. Recent Developments
  • 9.4. Endo Pharmaceuticals, Inc.
    • 9.4.1. Company Overview
    • 9.4.2. Product Portfolio
    • 9.4.3. Financial Overview
    • 9.4.4. Business Strategy
    • 9.4.5. Recent Developments
  • 9.5. GlaxoSmithKline plc
    • 9.5.1. Company Overview
    • 9.5.2. Product Portfolio
    • 9.5.3. Financial Overview
    • 9.5.4. Business Strategy
    • 9.5.5. Recent Developments
  • 9.6. Johnson & Johnson
    • 9.6.1. Company Overview
    • 9.6.2. Product Portfolio
    • 9.6.3. Financial Overview
    • 9.6.4. Business Strategy
    • 9.6.5. Recent Developments
  • 9.7. Mallinckrodt Pharmaceuticals
    • 9.7.1. Company Overview
    • 9.7.2. Product Portfolio
    • 9.7.3. Financial Overview
    • 9.7.4. Business Strategy
    • 9.7.5. Recent Developments
  • 9.8. Merck & Co., Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Product Portfolio
    • 9.8.3. Financial Overview
    • 9.8.4. Business Strategy
    • 9.8.5. Recent Developments
  • 9.9. Novartis AG
    • 9.9.1. Company Overview
    • 9.9.2. Product Portfolio
    • 9.9.3. Financial Overview
    • 9.9.4. Business Strategy
    • 9.9.5. Recent Developments
  • 9.10. Pfizer, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Product Portfolio
    • 9.10.3. Financial Overview
    • 9.10.4. Business Strategy
    • 9.10.5. Recent Developments
  • 9.11. Purdue Pharma L.P.
    • 9.11.1. Company Overview
    • 9.11.2. Product Portfolio
    • 9.11.3. Financial Overview
    • 9.11.4. Business Strategy
    • 9.11.5. Recent Developments
  • 9.12. Teva Pharmaceutical Industries Limited
    • 9.12.1. Company Overview
    • 9.12.2. Product Portfolio
    • 9.12.3. Financial Overview
    • 9.12.4. Business Strategy
    • 9.12.5. Recent Developments

List of Figures

  • FIG. 1: Market Segmentation
  • FIG. 2: Global Pain Management Therapeutics Market Share, by Geography, 2015
  • FIG. 3: Global Pain Management Therapeutics Market Share, by Geography, 2024
  • FIG. 4: Global Pain Management Therapeutics Market Revenue, By Therapeutics, (US$ Mn), 2015
  • FIG. 5: Global Pain Management Therapeutics Market Revenue, By Indication, (US$ Mn), 2015
  • FIG. 6: Pain Management Therapeutics Market, by Geography, 2015
  • FIG. 7: Global Anticonvulsants Market Revenue, (US$ Mn), 2014-2024
  • FIG. 8: Global Antidepressants Market Revenue, (US$ Mn), 2014-2024
  • FIG. 9: Global Anesthetics Market Revenue, (US$ Mn), 2014-2024
  • FIG. 10: Global Non-steroidal Anti-inflammatory Drugs (NSAIDS) Market Revenue, (US$ Mn) 2014-2024
  • FIG. 11: Global Oxycodones Market Revenue, (US$ Mn), 2014-2024
  • FIG. 12: Global Hydrocodones Market Revenue, (US$ Mn), 2014-2024
  • FIG. 13: Global Tramadol Market Revenue, (US$ Mn) 2014-2024
  • FIG. 14: Global Other Opioids Market Revenue, (US$ Mn), 2014-2024
  • FIG. 15: Global Antimigraine Agents Market Revenue, (US$ Mn), 2014-2024
  • FIG. 16: Global other non-narcotic analgesic Market Revenue, (US$ Mn), 2014-2024
  • FIG. 17: Global Neuropathic Pain Market Revenue, (US$ Mn), 2014-2024
  • FIG. 18: Global Fibromyalgia Market Revenue, (US$ Mn), 2014-2024
  • FIG. 19: Global Arthritic Pain Market Revenue, (US$ Mn), 2014-2024
  • FIG. 20: Global Chronic Back Pain Market Revenue, (US$ Mn), 2014-2024
  • FIG. 21: Global Migraine Market Revenue, (US$ Mn), 2014-2024
  • FIG. 22: Global Post-operative Pain Market Revenue, (US$ Mn), 2014-2024
  • FIG. 23: Global Cancer Pain Market Revenue, (US$ Mn), 2014-2024
  • FIG. 24: Market Share by Marketing Status (Branded & Generic Pharmaceuticals), 2015 (%)
  • FIG. 25: Market Share by Key Players: Branded Pharmaceuticals, 2015 (%)
  • FIG. 26: North America Pain Management Therapeutics Market Revenue, by Therapeutic, 2015
  • FIG. 27: North America Pain Management Therapeutics Market Revenue, by Therapeutic, 2024
  • FIG. 28: North America Opioids Market Revenue, by Therapeutic, (US$ Mn), 2014-2024
  • FIG. 29: North America Pain Management Therapeutics Market Revenue, by Indication, 2015
  • FIG. 30: North America Pain Management Therapeutics Market Revenue, by Indication, 2024
  • FIG. 31: Europe Pain Management Therapeutics Market Revenue, by Therapeutic, 2015
  • FIG. 32: Europe Pain Management Therapeutics Market Revenue, by Therapeutic, 2024
  • FIG. 33: Europe Opioids Market Revenue, by Therapeutics, (US$ Mn) 2014-2024
  • FIG. 34: Europe Pain Management Therapeutics Market Revenue, by Indication, 2015
  • FIG. 35: Europe Pain Management Therapeutics Market Revenue, by Indication, 2024
  • FIG. 36: Asia Pacific Pain Management Therapeutics Market Revenue, by Therapeutic, 2015
  • FIG. 37: Asia Pacific Pain Management Therapeutics Market Revenue, by Therapeutic, 2024
  • FIG. 38: Asia Pacific Opioids Market Revenue, by Therapeutic, (US$ Mn), 2014-2024
  • FIG. 39: Asia Pacific Pain Management Therapeutics Market Revenue, by Indication, 2015
  • FIG. 40: Asia Pacific Pain Management Therapeutics Market Revenue, by Indication, 2024
  • FIG. 41: Rest of the World Pain Management Therapeutics Market Revenue, by Therapeutic, 2015
  • FIG. 42: Rest of the World Pain Management Therapeutics Market Revenue, by Therapeutic, 2024
  • FIG. 43: Rest of the World Opioids Market Revenue, by Therapeutic, (US$ Mn), 2014-2024
  • FIG. 44: Rest of the world Pain Management Therapeutics Market Revenue, by Indication, 2015
  • FIG. 45: Rest of the World Pain Management Therapeutics Market Revenue, by Indication, 2024
  • FIG. 46: U.S. Pain Management Therapeutics Market
  • FIG. 47: Canada Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • FIG. 48: U.K. Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • FIG. 49: Germany Pain Management Therapeutics Market
  • FIG. 50: China Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • FIG. 51: Japan Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • FIG. 52: Brazil Pain Management Therapeutics Market Revenue (US$ Mn) 2014-2024
  • FIG. 53: Financial Details of Abbott Laboratories (US$ Mn), 2013-2015
  • FIG. 54: Financial Details of AstraZeneca (US$ Mn), 2013-2015
  • FIG. 55: Financial Details of Depomed, Inc. (US$ Mn), 2013-2015
  • FIG. 56: Financial Details of Endo Pharmaceuticals, Inc. (US$ Mn), 2013-2015
  • FIG. 57: Financial Details of GlaxoSmithKline plc(US$ Mn), 2013-2015
  • FIG. 58: Financial Details of Johnson & Johnson (US$ Mn), 2013-2015
  • FIG. 59: Financial Details of Mallinckrodt Pharmaceuticals (US$ Mn), 2013-2015
  • FIG. 60: Financial Details of Merck & Co., Inc. (US$ Mn), 2013-2015
  • FIG. 61: Financial Details of Novartis AG (US$ Mn), 2013-2015
  • FIG. 62: Financial Details of Pfizer, Inc. (US$ Mn), 2013-2015
  • FIG. 63: Financial Details of Purdue Pharma L.P. (US$ Mn), 2013-2015
  • FIG. 64: Financial Details of Teva Pharmaceutical Industries Limited (US$ Mn), 2013-2015

List of Tables

  • TABLE 1: Pain Management Therapeutics Market, 2016-2024: Market Snapshot
  • TABLE 2: Global Pain Management Therapeutics Market Analysis, By Therapeutics (US$ Mn), 2014 - 2024
  • TABLE 3: Global Opioids Market Revenue, by Type, (US$ Mn), 2014-2024
  • TABLE 4: Global Pain Management Therapeutics Market Revenue, by Indication, (US$ Mn), 2014-2024
  • TABLE 5: North America Pain Management Therapeutics Market Revenue, by Therapeutic, (US$ Mn), 2014-2024
  • TABLE 6: North America Pain Management Therapeutics Market Revenue, by Indication, (US$ Mn) 2014-2024
  • TABLE 7: Europe Pain Management Therapeutics Market Revenue, by Therapeutic, (US$ Mn), 2014-2024
  • TABLE 8: Europe Pain Management Therapeutics Market Revenue, by Indication, (US$ Mn), 2014-2024
  • TABLE 9: Asia Pacific Pain Management Therapeutics Market Revenue, by Therapeutic, (US$ Mn), 2014-2024
  • TABLE 10: Asia Pacific Pain Management Therapeutics Market Revenue, by Indication, (US$ Mn), 2014-2024
  • TABLE 11: Rest of the World Pain Management Therapeutics Market Revenue, by Therapeutic, (US$ Mn), 2014-2024
  • TABLE 12: Rest of the World Pain Management Therapeutics Market Revenue, by Indication, (US$ Mn), 2014-2024
  • TABLE 13: Pain Management Therapeutics Market Revenue, by Country, (US$ Mn), 2014-2024
Back to Top